Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2017 Filed Feb 15, 2017 16:41 UTC |
Field Edward L.President brtxDISC Division
|
Disposition to issuerOption · Derivative | 25,000 | Not disclosed Strike: $9.20 | Not disclosed |
DisclosureSEC source: 0001140361-17-007725 · doc1.xml · derivative · entry 1 Field Edward L. · CIK 0001435185 · President brtxDISC Division 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2025-02-09 F4 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F1 · derivative.exercise_date: The option vests to the extent of 8,334 shares on February 9, 2016 and 8,333 shares on each of February 9, 2017 and February 9, 2018. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:48 UTC |
Clyde Mandy D.VP of Operations
|
GrantStock Option · Derivative | 25,500 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007738 · doc1.xml · derivative · entry 16 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,500 Underlying: Common Stock · 25,500 shares Expires 2025-09-04 F9 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F7 · derivative.exercise_date: The option is exercisable to the extent of 8,500 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:48 UTC |
Clyde Mandy D.VP of Operations
|
Disposition to issuerStock Option · Derivative | 25,500 | Not disclosed Strike: $7.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-007738 · doc1.xml · derivative · entry 15 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,500 shares Expires 2025-09-04 F9 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F7 · derivative.exercise_date: The option is exercisable to the extent of 8,500 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:48 UTC |
Clyde Mandy D.VP of Operations
|
GrantStock Option · Derivative | 10,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007738 · doc1.xml · derivative · entry 14 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2024-10-23 F9 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F6 · derivative.exercise_date: The option is exercisable to the extent of 3,334 shares on October 23, 2015 and 3,333 shares on each of October 23, 2016 and October 23, 2017. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:48 UTC |
Clyde Mandy D.VP of Operations
|
Disposition to issuerStock Option · Derivative | 10,000 | Not disclosed Strike: $6.60 | Not disclosed |
DisclosureSEC source: 0001140361-17-007738 · doc1.xml · derivative · entry 13 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2024-10-23 F9 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F6 · derivative.exercise_date: The option is exercisable to the extent of 3,334 shares on October 23, 2015 and 3,333 shares on each of October 23, 2016 and October 23, 2017. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:48 UTC |
Clyde Mandy D.VP of Operations
|
GrantStock Option · Derivative | 6,250 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007738 · doc1.xml · derivative · entry 12 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 6,250 shares Expires 2024-02-18 F9 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F5 · derivative.exercise_date: The option is exercisable to the extent of 2,084 shares on February 18, 2014, and 2,083 shares on each of February 18, 2015 and February 18, 2016. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:48 UTC |
Clyde Mandy D.VP of Operations
|
Disposition to issuerStock Option · Derivative | 6,250 | Not disclosed Strike: $13.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-007738 · doc1.xml · derivative · entry 11 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,250 shares Expires 2024-02-18 F9 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F5 · derivative.exercise_date: The option is exercisable to the extent of 2,084 shares on February 18, 2014, and 2,083 shares on each of February 18, 2015 and February 18, 2016. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:48 UTC |
Clyde Mandy D.VP of Operations
|
GrantStock Option · Derivative | 4,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007738 · doc1.xml · derivative · entry 10 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2023-10-04 F9 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F4 · derivative.exercise_date: The option is exercisable to the extent of 2,000 shares on each of October 4, 2013 and October 4, 2014. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:48 UTC |
Clyde Mandy D.VP of Operations
|
Disposition to issuerStock Option · Derivative | 4,000 | Not disclosed Strike: $12.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-007738 · doc1.xml · derivative · entry 9 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2023-10-04 F9 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F4 · derivative.exercise_date: The option is exercisable to the extent of 2,000 shares on each of October 4, 2013 and October 4, 2014. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:48 UTC |
Clyde Mandy D.VP of Operations
|
GrantStock Option · Derivative | 2,500 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007738 · doc1.xml · derivative · entry 8 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2022-12-07 F9 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F3 · derivative.exercise_date: The option is exercisable to the extent of 1,250 shares on each of December 7, 2012 and December 7, 2013. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:48 UTC |
Clyde Mandy D.VP of Operations
|
Disposition to issuerStock Option · Derivative | 2,500 | Not disclosed Strike: $30.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-007738 · doc1.xml · derivative · entry 7 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2022-12-07 F9 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F3 · derivative.exercise_date: The option is exercisable to the extent of 1,250 shares on each of December 7, 2012 and December 7, 2013. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:48 UTC |
Clyde Mandy D.VP of Operations
|
GrantStock Option · Derivative | 1,500 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007738 · doc1.xml · derivative · entry 6 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires 2022-02-09 F9 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F2 · derivative.exercise_date: The option is exercisable to the extent of 750 shares on each of February 10, 2012 and February 10, 2013. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:48 UTC |
Clyde Mandy D.VP of Operations
|
Disposition to issuerStock Option · Derivative | 1,500 | Not disclosed Strike: $21.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-007738 · doc1.xml · derivative · entry 5 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2022-02-09 F9 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F2 · derivative.exercise_date: The option is exercisable to the extent of 750 shares on each of February 10, 2012 and February 10, 2013. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:48 UTC |
Clyde Mandy D.VP of Operations
|
GrantStock Option · Derivative | 300 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007738 · doc1.xml · derivative · entry 4 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 Underlying: Common Stock · 300 shares Expires 2021-04-20 F9 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F1 · derivative.exercise_date: The option is exercisable to the extent of 100 shares on each of April 21, 2011, April 21, 2012 and April 21, 2013. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:48 UTC |
Clyde Mandy D.VP of Operations
|
Disposition to issuerStock Option · Derivative | 300 | Not disclosed Strike: $20.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-007738 · doc1.xml · derivative · entry 3 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 300 shares Expires 2021-04-20 F9 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F1 · derivative.exercise_date: The option is exercisable to the extent of 100 shares on each of April 21, 2011, April 21, 2012 and April 21, 2013. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:48 UTC |
Clyde Mandy D.VP of Operations
|
GrantStock Option · Derivative | 4,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007738 · doc1.xml · derivative · entry 2 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2020-12-14 F9 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:48 UTC |
Clyde Mandy D.VP of Operations
|
Disposition to issuerStock Option · Derivative | 4,000 | Not disclosed Strike: $10.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-007738 · doc1.xml · derivative · entry 1 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2020-12-14 F9 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:39 UTC |
Silva FranciscoVP of Research and Development
|
GrantStock Option · Derivative | 25,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007721 · doc1.xml · derivative · entry 24 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2025-09-04 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F8 · derivative.exercise_date: The option is exercisable to the extent of 8,334 shares on September 4, 2016 and 8,333 shares on each of September 4, 2017 and September 4, 2018. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:39 UTC |
Silva FranciscoVP of Research and Development
|
Disposition to issuerStock Option · Derivative | 25,000 | Not disclosed Strike: $7.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-007721 · doc1.xml · derivative · entry 23 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2025-09-04 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F8 · derivative.exercise_date: The option is exercisable to the extent of 8,334 shares on September 4, 2016 and 8,333 shares on each of September 4, 2017 and September 4, 2018. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:39 UTC |
Silva FranciscoVP of Research and Development
|
GrantStock Option · Derivative | 37,500 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007721 · doc1.xml · derivative · entry 22 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2024-10-23 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F7 · derivative.exercise_date: The option is exercisable to the extent of 12,500 shares on each of October 23, 2015, October 23, 2016 and October 23, 2017. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:39 UTC |
Silva FranciscoVP of Research and Development
|
Disposition to issuerStock Option · Derivative | 37,500 | Not disclosed Strike: $6.60 | Not disclosed |
DisclosureSEC source: 0001140361-17-007721 · doc1.xml · derivative · entry 21 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,500 shares Expires 2024-10-23 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F7 · derivative.exercise_date: The option is exercisable to the extent of 12,500 shares on each of October 23, 2015, October 23, 2016 and October 23, 2017. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:39 UTC |
Silva FranciscoVP of Research and Development
|
GrantStock Option · Derivative | 2,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007721 · doc1.xml · derivative · entry 20 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2022-05-02 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:39 UTC |
Silva FranciscoVP of Research and Development
|
Disposition to issuerStock Option · Derivative | 2,000 | Not disclosed Strike: $28.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-007721 · doc1.xml · derivative · entry 19 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2022-05-02 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:39 UTC |
Silva FranciscoVP of Research and Development
|
GrantStock Option · Derivative | 2,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007721 · doc1.xml · derivative · entry 18 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2024-03-11 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:39 UTC |
Silva FranciscoVP of Research and Development
|
Disposition to issuerStock Option · Derivative | 2,000 | Not disclosed Strike: $10.60 | Not disclosed |
DisclosureSEC source: 0001140361-17-007721 · doc1.xml · derivative · entry 17 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2024-03-11 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:39 UTC |
Silva FranciscoVP of Research and Development
|
GrantStock Option · Derivative | 12,500 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007721 · doc1.xml · derivative · entry 16 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2024-02-18 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F6 · derivative.exercise_date: The option is exercisable to the extent of 4,167 shares on each of February 18, 2014 and February 18, 2015, and 4,166 shares on February 18, 2016. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:39 UTC |
Silva FranciscoVP of Research and Development
|
Disposition to issuerStock Option · Derivative | 12,500 | Not disclosed Strike: $13.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-007721 · doc1.xml · derivative · entry 15 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2024-02-18 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F6 · derivative.exercise_date: The option is exercisable to the extent of 4,167 shares on each of February 18, 2014 and February 18, 2015, and 4,166 shares on February 18, 2016. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:39 UTC |
Silva FranciscoVP of Research and Development
|
GrantStock Option · Derivative | 5,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007721 · doc1.xml · derivative · entry 14 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2023-10-04 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F5 · derivative.exercise_date: The option is exercisable to the extent of 2,500 shares on each of October 4, 2013 and October 4, 2014. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:39 UTC |
Silva FranciscoVP of Research and Development
|
Disposition to issuerStock Option · Derivative | 5,000 | Not disclosed Strike: $12.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-007721 · doc1.xml · derivative · entry 13 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2023-10-04 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F5 · derivative.exercise_date: The option is exercisable to the extent of 2,500 shares on each of October 4, 2013 and October 4, 2014. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:39 UTC |
Silva FranciscoVP of Research and Development
|
GrantStock Option · Derivative | 4,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007721 · doc1.xml · derivative · entry 12 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2022-12-07 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F4 · derivative.exercise_date: The option is exercisable to the extent of 2,000 shares on each of December 7, 2012 and December 7, 2013. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:39 UTC |
Silva FranciscoVP of Research and Development
|
Disposition to issuerStock Option · Derivative | 4,000 | Not disclosed Strike: $30.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-007721 · doc1.xml · derivative · entry 11 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2022-12-07 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F4 · derivative.exercise_date: The option is exercisable to the extent of 2,000 shares on each of December 7, 2012 and December 7, 2013. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:39 UTC |
Silva FranciscoVP of Research and Development
|
GrantStock Option · Derivative | 5,500 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007721 · doc1.xml · derivative · entry 10 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 5,500 shares Expires 2022-05-02 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F3 · derivative.exercise_date: The option is exercisable to the extent of 500 shares on each of May 3, 2013, May 3, 2014 and May 3, 2015, became exercisable to the extent of 1,000 shares based on the satisfaction of certain conditions and is exercisable to the extent of 3,000 shares subject to the satisfaction of certain conditions. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:39 UTC |
Silva FranciscoVP of Research and Development
|
Disposition to issuerStock Option · Derivative | 5,500 | Not disclosed Strike: $28.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-007721 · doc1.xml · derivative · entry 9 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,500 shares Expires 2022-05-02 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F3 · derivative.exercise_date: The option is exercisable to the extent of 500 shares on each of May 3, 2013, May 3, 2014 and May 3, 2015, became exercisable to the extent of 1,000 shares based on the satisfaction of certain conditions and is exercisable to the extent of 3,000 shares subject to the satisfaction of certain conditions. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:39 UTC |
Silva FranciscoVP of Research and Development
|
GrantStock Option · Derivative | 2,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007721 · doc1.xml · derivative · entry 8 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2022-02-09 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F2 · derivative.exercise_date: The option is exercisable to the extent of 1,000 shares on each of February 10, 2012 and February 10, 2013. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:39 UTC |
Silva FranciscoVP of Research and Development
|
Disposition to issuerStock Option · Derivative | 2,000 | Not disclosed Strike: $21.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-007721 · doc1.xml · derivative · entry 7 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2022-02-09 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F2 · derivative.exercise_date: The option is exercisable to the extent of 1,000 shares on each of February 10, 2012 and February 10, 2013. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:39 UTC |
Silva FranciscoVP of Research and Development
|
GrantStock Option · Derivative | 1,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007721 · doc1.xml · derivative · entry 6 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2021-11-15 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:39 UTC |
Silva FranciscoVP of Research and Development
|
Disposition to issuerStock Option · Derivative | 1,000 | Not disclosed Strike: $20.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-007721 · doc1.xml · derivative · entry 5 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2021-11-15 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:39 UTC |
Silva FranciscoVP of Research and Development
|
GrantStock Option · Derivative | 150 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007721 · doc1.xml · derivative · entry 4 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150 Underlying: Common Stock · 150 shares Expires 2021-06-23 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:39 UTC |
Silva FranciscoVP of Research and Development
|
Disposition to issuerStock Option · Derivative | 150 | Not disclosed Strike: $25.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-007721 · doc1.xml · derivative · entry 3 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 150 shares Expires 2021-06-23 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:39 UTC |
Silva FranciscoVP of Research and Development
|
GrantStock Option · Derivative | 4,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007721 · doc1.xml · derivative · entry 2 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2021-04-04 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F1 · derivative.exercise_date: The option is exercisable to the extent of 2,000 shares on each of April 5, 2011 and April 5, 2012. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:39 UTC |
Silva FranciscoVP of Research and Development
|
Disposition to issuerStock Option · Derivative | 4,000 | Not disclosed Strike: $10.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-007721 · doc1.xml · derivative · entry 1 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2021-04-04 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F1 · derivative.exercise_date: The option is exercisable to the extent of 2,000 shares on each of April 5, 2011 and April 5, 2012. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:36 UTC |
Radov A. JeffreyDirector
|
GrantStock Option · Derivative | 115,500 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007717 · doc1.xml · derivative · entry 13 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,500 Underlying: Common Stock · 115,500 shares Expires 2025-09-04 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F6 · derivative.exercise_date: The option is exercisable to the extent of 57,750 shares on December 22, 2015, and 19,250 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:36 UTC |
Radov A. JeffreyDirector
|
Disposition to issuerStock Option · Derivative | 115,500 | Not disclosed Strike: $7.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-007717 · doc1.xml · derivative · entry 12 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 115,500 shares Expires 2025-09-04 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F6 · derivative.exercise_date: The option is exercisable to the extent of 57,750 shares on December 22, 2015, and 19,250 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:36 UTC |
Radov A. JeffreyDirector
|
GrantStock Option · Derivative | 50,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007717 · doc1.xml · derivative · entry 11 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2024-10-23 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F5 · derivative.exercise_date: The option is exercisable to the extent of 16,667 shares on each of October 23, 2015 and Octobe 23, 2016 and 16,666 shares on October 23, 2017. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:36 UTC |
Radov A. JeffreyDirector
|
Disposition to issuerStock Option · Derivative | 50,000 | Not disclosed Strike: $6.60 | Not disclosed |
DisclosureSEC source: 0001140361-17-007717 · doc1.xml · derivative · entry 10 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2024-10-23 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F5 · derivative.exercise_date: The option is exercisable to the extent of 16,667 shares on each of October 23, 2015 and Octobe 23, 2016 and 16,666 shares on October 23, 2017. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:36 UTC |
Radov A. JeffreyDirector
|
GrantStock Option · Derivative | 25,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007717 · doc1.xml · derivative · entry 9 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2024-02-18 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F4 · derivative.exercise_date: The option is exercisable to the extent of 8,334 shares on February 18, 2014, and 8,333 shares on each of February 18, 2015 and February 18, 2016. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:36 UTC |
Radov A. JeffreyDirector
|
Disposition to issuerStock Option · Derivative | 25,000 | Not disclosed Strike: $13.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-007717 · doc1.xml · derivative · entry 8 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2024-02-18 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F4 · derivative.exercise_date: The option is exercisable to the extent of 8,334 shares on February 18, 2014, and 8,333 shares on each of February 18, 2015 and February 18, 2016. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:36 UTC |
Radov A. JeffreyDirector
|
GrantStock Option · Derivative | 12,500 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007717 · doc1.xml · derivative · entry 7 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2023-10-04 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F3 · derivative.exercise_date: The option is exercisable to the extent of 6,250 shares on each of October 4, 2013 and October 4, 2014. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:36 UTC |
Radov A. JeffreyDirector
|
Disposition to issuerStock Option · Derivative | 12,500 | Not disclosed Strike: $12.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-007717 · doc1.xml · derivative · entry 6 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2023-10-04 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F3 · derivative.exercise_date: The option is exercisable to the extent of 6,250 shares on each of October 4, 2013 and October 4, 2014. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:36 UTC |
Radov A. JeffreyDirector
|
GrantStock Option · Derivative | 5,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007717 · doc1.xml · derivative · entry 5 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2022-12-07 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F2 · derivative.exercise_date: The option is exercisable to the extent of 2,500 shares on each of December 7, 2012 and December 7, 2013. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.